Literature DB >> 18413868

Guideline: dementia drugs' benefits uncertain.

Rebecca Voelker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18413868     DOI： 10.1001/jama.299.15.1763

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The importance of cognitive aging for understanding dementia.

Authors:  Archana Singh-Manoux; Mika Kivimäki
Journal:  Age (Dordr)       Date:  2010-05-08

Review 2.  Phasic acetylcholine release and the volume transmission hypothesis: time to move on.

Authors:  Martin Sarter; Vinay Parikh; W Matthew Howe
Journal:  Nat Rev Neurosci       Date:  2009-05       Impact factor: 34.870

Review 3.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  The timing of drug funding announcements relative to elections: a case study involving dementia medications.

Authors:  Sudeep S Gill; Neeraj Gupta; Chaim M Bell; Paula A Rochon; Peter C Austin; Andreas Laupacis
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.